VCYT · Company research
Veracyte, Inc. (VCYT): Valuation Analysis
Available valuation snapshots and ratios; unavailable metrics remain blank.
RESEARCH CONTEXT
Understand the numbers
Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.
1records availableHealthcare
Valuation Analysis data
Database-backed records only
| valuation date | price | market cap | enterprise value | pe | forward pe | peg | price sales | price book | price fcf |
|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | 44.65 | $3,781,299,087.36 | 3481778087.36 | 148.6451612903225806 | — | — | 25.1548292478096873 | 2.7234881279858946 | 88.00472658924290734742 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.